IL1B and disease of the tendon: In conclusion, our results revealed the two formulations, cHA (50:50) + DEX and cHA (20:80) + DEX, ameliorate tendinopathy via anti-apoptotic and anti-senescent effects in IL-1β-stimulated tendinopathic tenocytes and a rat collagenase-induced tendinopathy model.